Page last updated: 2024-10-21

3-aminobenzamide and Mesenteric Vascular Occlusion

3-aminobenzamide has been researched along with Mesenteric Vascular Occlusion in 1 studies

Mesenteric Vascular Occlusion: Obstruction of the flow in the SPLANCHNIC CIRCULATION by ATHEROSCLEROSIS; EMBOLISM; THROMBOSIS; STENOSIS; TRAUMA; and compression or intrinsic pressure from adjacent tumors. Rare causes are drugs, intestinal parasites, and vascular immunoinflammatory diseases such as PERIARTERITIS NODOSA and THROMBOANGIITIS OBLITERANS. (From Juergens et al., Peripheral Vascular Diseases, 5th ed, pp295-6)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cuzzocrea, S1
Zingarelli, B1
Costantino, G1
Szabó, A1
Salzman, AL1
Caputi, AP1
Szabó, C1

Other Studies

1 other study available for 3-aminobenzamide and Mesenteric Vascular Occlusion

ArticleYear
Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion.
    British journal of pharmacology, 1997, Volume: 121, Issue:6

    Topics: Animals; Benzamides; Blood Pressure; Cell Membrane Permeability; Enzyme Activation; Enzyme Inhibitor

1997